• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

系统性硬化症患者双阴性T细胞的免疫谱分析

Immune profiling analysis of double-negative T cells in patients with systemic sclerosis.

作者信息

Zhang Dongdong, Alip Mihribangvl, Chen Hongzhen, Wu Dan, Zhu Huimin, Han Yichen, Yuan Xinran, Feng Xuebing, Sun Lingyun, Wang Dandan

机构信息

Department of Rheumatology and Immunology, Affiliated Hospital of Medical School, Nanjing Drum Tower Hospital, Nanjing University. Nanjing, Jiangsu, 210008, China.

Nanjing Drum Tower Hospital Clinical College of Nanjing University of Chinese Medicine Nanjing, Jiangsu, 210008, China.

出版信息

Clin Rheumatol. 2024 May;43(5):1623-1634. doi: 10.1007/s10067-024-06920-9. Epub 2024 Mar 4.

DOI:10.1007/s10067-024-06920-9
PMID:38436769
Abstract

OBJECTIVE

To construct a molecular immune map of patients with systemic sclerosis (SSc) by mass flow cytometry, and compare the number and molecular expression of double-negative T (DNT) cell subsets between patients and healthy controls (HC).

METHODS

Peripheral blood mononuclear cells (PBMCs) were extracted from the peripheral blood of 17 SSc patients and 9 HC. A 42-channel panel was set up to perform mass cytometry by time of flight (CyTOF) analysis for DNT subgroups. Flow cytometry was used to validate subpopulation functions. The clinical data of patients were collected for correlation analysis.

RESULTS

Compared with HC, the number of total DNT cells decreased in SSc patients. Six DNT subsets were obtained from CyTOF analysis, in which the proportion of cluster1 increased, while the proportion of cluster3 decreased. Further analysis revealed that cluster1 was characterized by high expression of CD28 and CCR7, and cluster3 was characterized by high expression of CD28 and CCR5. After in vitro stimulation, cluster1 secreted more IL-4 and cluster3 secreted more IL-10 in SSc patients compared to HC. Clinical correlation analysis suggested that cluster1 may play a pathogenic role while cluster3 may play a protective role in SSc. ROC curve analysis further revealed that cluster3 may be a potential indicator for determining disease activity in SSc patients.

CONCLUSION

We found a new CCR5CD28 DNT cell subset, which played a protective role in the pathogenesis of SSc. Key Points • The number of DNT cells decreased in SSc patients' peripheral blood. • DNT cells do not infiltrate in the skin but secrete cytokines to participate in the pathogenesis of SSc. • A CCR5CD28 DNT cell population may play a protective role in SSc.

摘要

目的

通过质谱流式细胞术构建系统性硬化症(SSc)患者的分子免疫图谱,并比较患者与健康对照(HC)之间双阴性T(DNT)细胞亚群的数量和分子表达。

方法

从17例SSc患者和9例HC的外周血中提取外周血单个核细胞(PBMC)。设置一个42通道的面板,通过飞行时间质谱流式细胞术(CyTOF)分析DNT亚群。采用流式细胞术验证亚群功能。收集患者的临床资料进行相关性分析。

结果

与HC相比,SSc患者中总DNT细胞数量减少。通过CyTOF分析获得了6个DNT亚群,其中cluster1的比例增加,而cluster3的比例降低。进一步分析显示,cluster1的特征是CD28和CCR7高表达,cluster3的特征是CD28和CCR5高表达。体外刺激后,与HC相比,SSc患者中cluster1分泌更多的IL-4,cluster3分泌更多的IL-10。临床相关性分析表明,cluster1可能在SSc中起致病作用,而cluster3可能起保护作用。ROC曲线分析进一步显示,cluster3可能是确定SSc患者疾病活动度的潜在指标。

结论

我们发现了一个新的CCR5CD28 DNT细胞亚群,其在SSc发病机制中起保护作用。要点•SSc患者外周血中DNT细胞数量减少。•DNT细胞不浸润皮肤,但分泌细胞因子参与SSc的发病机制。•一个CCR5CD28 DNT细胞群体可能在SSc中起保护作用。

相似文献

1
Immune profiling analysis of double-negative T cells in patients with systemic sclerosis.系统性硬化症患者双阴性T细胞的免疫谱分析
Clin Rheumatol. 2024 May;43(5):1623-1634. doi: 10.1007/s10067-024-06920-9. Epub 2024 Mar 4.
2
Lymphocyte subset abnormalities in early diffuse cutaneous systemic sclerosis.早期弥漫性皮肤系统性硬化症中的淋巴细胞亚群异常
Arthritis Res Ther. 2021 Jan 6;23(1):10. doi: 10.1186/s13075-020-02383-w.
3
Increased Expression and Modulated Regulatory Activity of Coinhibitory Receptors PD-1, TIGIT, and TIM-3 in Lymphocytes From Patients With Systemic Sclerosis.系统性硬化症患者淋巴细胞中共抑制受体 PD-1、TIGIT 和 TIM-3 的表达增加和调节活性改变。
Arthritis Rheumatol. 2018 Apr;70(4):566-577. doi: 10.1002/art.40399. Epub 2018 Mar 7.
4
Different profile of cytokine production in patients with systemic sclerosis and association with clinical manifestations.系统性硬化症患者细胞因子产生的不同特征及其与临床表现的关联。
Immunol Lett. 2018 Jun;198:12-16. doi: 10.1016/j.imlet.2018.03.011. Epub 2018 Mar 27.
5
Dysregulated CD25 and Cytokine Expression by γδ T Cells of Systemic Sclerosis Patients Stimulated With Cardiolipin and Zoledronate.系统性硬皮病患者 γδ T 细胞受心磷脂和唑来膦酸刺激后 CD25 和细胞因子表达失调。
Front Immunol. 2018 Apr 13;9:753. doi: 10.3389/fimmu.2018.00753. eCollection 2018.
6
[Application of lymphocytes test in peripheral blood of patients with systemic sclerosis during the treatment].[淋巴细胞检测在系统性硬化症患者治疗期间外周血中的应用]
Beijing Da Xue Xue Bao Yi Xue Ban. 2021 Aug 18;53(4):721-727. doi: 10.19723/j.issn.1671-167X.2021.04.017.
7
Altered B lymphocyte homeostasis and functions in systemic sclerosis.系统性硬化症中 B 淋巴细胞的稳态和功能改变。
Autoimmun Rev. 2018 Mar;17(3):244-255. doi: 10.1016/j.autrev.2017.10.015. Epub 2018 Jan 16.
8
Increased expression of the ectoenzyme CD38 in peripheral blood plasmablasts and plasma cells of patients with systemic sclerosis.系统性硬化症患者外周血浆母细胞和浆细胞中细胞外酶 CD38 的表达增加。
Front Immunol. 2022 Dec 21;13:1072462. doi: 10.3389/fimmu.2022.1072462. eCollection 2022.
9
Regulatory T cells produce profibrotic cytokines in the skin of patients with systemic sclerosis.调节性 T 细胞在系统性硬化症患者的皮肤中产生促纤维化细胞因子。
J Allergy Clin Immunol. 2015 Apr;135(4):946-955.e9. doi: 10.1016/j.jaci.2014.12.1932. Epub 2015 Feb 10.
10
Systemic Sclerosis Perturbs the Architecture of the Immunome.系统性硬化症扰乱了免疫组库的结构。
Front Immunol. 2020 Aug 6;11:1602. doi: 10.3389/fimmu.2020.01602. eCollection 2020.

引用本文的文献

1
Pathogenesis of systemic sclerosis: an integrative review of recent advances.系统性硬化症的发病机制:近期进展的综合综述
J Rheum Dis. 2025 Apr 1;32(2):89-104. doi: 10.4078/jrd.2024.0129. Epub 2024 Nov 28.
2
Single-cell mass cytometry in immunological skin diseases.单细胞质谱流式细胞术在免疫性皮肤病中的应用。
Front Immunol. 2024 Jul 16;15:1401102. doi: 10.3389/fimmu.2024.1401102. eCollection 2024.
3
Regarding the double-negative T cells in patients with systemic sclerosis.

本文引用的文献

1
Assessment of disease outcome measures in systemic sclerosis.系统性硬化病的疾病结局评估。
Nat Rev Rheumatol. 2022 Sep;18(9):527-541. doi: 10.1038/s41584-022-00803-6. Epub 2022 Jul 20.
2
LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.LINC00853 通过调控 CCR9/CCL25 抑制 T 细胞急性淋巴细胞白血病的侵袭和浸润。
Mol Immunol. 2021 Dec;140:267-275. doi: 10.1016/j.molimm.2021.10.016. Epub 2021 Nov 20.
3
scRNA-seq of human vitiligo reveals complex networks of subclinical immune activation and a role for CCR5 in T function.
Clin Rheumatol. 2024 Jul;43(7):2361. doi: 10.1007/s10067-024-06989-2. Epub 2024 May 13.
人类白癜风的单细胞RNA测序揭示了亚临床免疫激活的复杂网络以及CCR5在T细胞功能中的作用。
Sci Transl Med. 2021 Sep 8;13(610):eabd8995. doi: 10.1126/scitranslmed.abd8995.
4
Treatment for systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关间质性肺疾病的治疗。
Curr Opin Rheumatol. 2021 May 1;33(3):240-248. doi: 10.1097/BOR.0000000000000795.
5
CD4 derived double negative T cells prevent the development and progression of nonalcoholic steatohepatitis.CD4 衍生的双阴性 T 细胞可预防非酒精性脂肪性肝炎的发生和进展。
Nat Commun. 2021 Jan 28;12(1):650. doi: 10.1038/s41467-021-20941-x.
6
An update on the pharmacotherapeutic options and treatment strategies for systemic sclerosis.系统性硬皮病的药物治疗选择和治疗策略的最新进展。
Expert Opin Pharmacother. 2020 Nov;21(16):2041-2056. doi: 10.1080/14656566.2020.1793960. Epub 2020 Jul 17.
7
Systemic lupus erythematosus favors the generation of IL-17 producing double negative T cells.系统性红斑狼疮有利于产生产生白细胞介素-17 的双阴性 T 细胞。
Nat Commun. 2020 Jun 5;11(1):2859. doi: 10.1038/s41467-020-16636-4.
8
Systemic sclerosis-associated interstitial lung disease.系统性硬皮病相关性间质性肺疾病。
Lancet Respir Med. 2020 Mar;8(3):304-320. doi: 10.1016/S2213-2600(19)30480-1. Epub 2020 Feb 27.
9
αβ and γδ T cell receptors: Similar but different.αβ 和 γδ T 细胞受体:相似但不同。
J Leukoc Biol. 2020 Jun;107(6):1045-1055. doi: 10.1002/JLB.2MR1219-233R. Epub 2020 Jan 29.
10
Etiology, Risk Factors, and Biomarkers in Systemic Sclerosis with Interstitial Lung Disease.系统性硬化症伴间质性肺病的病因、危险因素和生物标志物。
Am J Respir Crit Care Med. 2020 Mar 15;201(6):650-660. doi: 10.1164/rccm.201903-0563CI.